SCHEMBL7490295

SCHEMBL7490295

COC(=O)[C@H](Cc1ccc(OCCCCNc2ncccn2)cc1)NC(=O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.60
RAB9A P51151 1/20 0.60
ITGB3 P05106 6/20 0.57
ITGA2B P08514 1/20 0.57
ITGB1 P05556 7/20 0.54
ITGA5 P08648 5/20 0.54
ITGAV P06756 5/20 0.51
PPARG P37231 1/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
GLA P06280 1/20 0.48
ITGA4 P13612 1/20 0.47
ITGB5 P18084 1/20 0.47
ITGB6 P18564 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
MDM4 O15151 1/20 0.46
MDM2 Q00987 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7490286 1.00 GAA (0.60) GAARAB9AITGB3ITGA2BITGB1
SCHEMBL7494247 0.91 ITGB3 (0.69) ITGB3ITGA2BITGB1ITGA5ITGAV
SCHEMBL7494281 0.91 ITGB3 (0.69) ITGB3ITGA2BITGB1ITGA5ITGAV
Hydrochloric Acid SCHEMBL7482009 0.90 ITGB3 (0.67) ITGB3ITGA2BITGB1ITGA5ITGAV
Hydrochloric Acid SCHEMBL7482028 0.90 ITGB3 (0.67) ITGB3ITGA2BITGB1ITGA5ITGAV
SCHEMBL8684162 0.86 GAA (0.55) GAARAB9AITGB3ITGA2BITGB1
SCHEMBL7490231 0.81 GAA (0.58) GAARAB9AITGB3ITGA2BALDH1A1
SCHEMBL22604667 0.80 GAA (0.91) GAARAB9AITGB3ITGA2BPPARG
SCHEMBL22604665 0.80 GAA (0.91) GAARAB9AITGB3ITGA2BPPARG
SCHEMBL4362510 0.80 GAA (0.71) GAARAB9AITGB3ITGA2BITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0760658-B1 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO INC (US) 2002-11-13 EP claimed
JP-2001524079-A 2001-11-27 JP claimed
EP-0973396-A4 A METHOD OF TREATING CANCER MERCK & CO INC (US) 2001-02-07 EP claimed
EP-0973396-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 2000-01-26 EP claimed
WO-1998044797-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1998-10-15 WO claimed
EP-0760658-A4 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO INC (US) 1997-09-17 EP claimed
EP-0760658-A1 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO. INC. (US) 1997-03-12 EP claimed
WO-1995032710-A1 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO., INC. (US) 1995-12-07 WO claimed
EP-0760658-B1 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO INC (US) 2002-11-13 EP disclosed
US-5929120-A Guainidino, formamidino, amino and related compounds for inhibiting osteoclast-mediated bone resorption MERCK & CO., INC. (US) 1999-07-27 US disclosed
US-5741796-A Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption MERCK & CO., INC. (US) 1998-04-21 US disclosed
EP-0760658-A4 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO INC (US) 1997-09-17 EP disclosed
EP-0760658-A1 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO. INC. (US) 1997-03-12 EP disclosed
WO-1995032710-A1 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO., INC. (US) 1995-12-07 WO disclosed